Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.
about
The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working PartyOutcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donorsRecent advances in treatment of aplastic anemia.Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials NeReduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia.Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.Reprogrammed cells for disease modeling and regenerative medicine.Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?Acquired aplastic anemia in children.The Efficacy of an Oral Elemental Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation.Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor.Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning.The optimal immunosuppressive therapy for aplastic anemia.Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.Hematopoietic stem cell transplantation for acquired aplastic anemia.A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.RETRACTED ARTICLE: Cotransplantation of human umbilical cord mesenchymal and haplo-hematopoietic stem cells in patients with severe aplastic anemia.Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation.Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia.Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemia.The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers.Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan.Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning.Diagnosis and Treatment of Aplastic Anemia.Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia.Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine.Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment
P2860
Q31122890-E3A0F310-0F97-4E09-8864-F77AB2B52D02Q33419679-E401C9D0-B0E4-4C78-887A-6699654304B9Q33886206-25C4E1BF-0AAB-4FE9-A69F-F01445D6A798Q34108254-B8355DD8-8C9E-4E1C-A9DD-E56C95B26AB1Q34371142-2A62B419-9B6D-49AA-BC69-5DA4AA4987F6Q34451351-713CD861-07D7-4518-B94E-BB0BFC92A57EQ34545908-2A3C36F8-A8A4-454C-8D08-3D306EFEEA0FQ34645147-943617B4-CD42-4B8C-B722-A0B8D4971184Q35110555-C92FC2C1-FA8C-424E-9BEE-56EC6A66FB41Q36133000-04B7E88D-0883-4F39-B5AA-2E96B72B518CQ36497220-58CF011A-0492-4E48-AA88-531147BC9D0AQ36776248-C5174424-42DD-4882-A02C-F64C155603F7Q37216480-4CCBE42F-E066-4498-AB4F-774C2C16E97CQ37482272-6508D36C-3FAB-4243-9DB1-7E156A0919D8Q37490754-4249753E-C7DB-43A7-A7C4-1EB4997152E7Q37616815-A93A60D4-09ED-4851-9EF2-34C0CC0B7123Q38061041-37714E72-0B55-4767-8923-E3DAB35D5BC7Q38065878-2FAE966A-E7B6-4290-88D5-61712011FB8EQ38100685-5A03B2D1-9CAF-4466-B822-350F9A5637C7Q38103184-65749032-80B8-4636-94EA-B39D5BE3035FQ38261555-3880CE15-C463-4592-A672-6540F014ABE1Q38740791-2C23783E-7D72-4413-B28D-656F1C02F47AQ38949394-70B8261F-12C9-4C29-8B77-CB2654258CB3Q39157279-1BBBC748-BF58-4682-ACAA-3B26D61FD732Q39972680-68E1E490-4699-464F-A5D3-E456E06D159FQ41376484-25D05E57-B4F0-46EA-A153-FC029E6431D2Q41455084-F9890EB6-50BA-44E3-8B30-69E3A2A959D0Q43531855-E37A717B-4285-449D-8C05-6575C7C66AA0Q44278687-FE432EC2-00C4-4289-B718-5B526AF17D98Q45764430-4FD0B128-4AA4-4086-92A3-CB321DEF906BQ45798911-98245AA6-1A36-4214-B58E-E70B110B5B29Q47126486-F13C571A-8F9E-42B7-AA08-91C2E24D3414Q47836932-54530D1D-BDEF-42D6-8BB6-EAEF175136D1Q47865904-88E0F79F-4144-4A44-9E2F-A55B4480F4C1Q48537627-E13ADEF5-0DD6-491B-909F-3ACD54009FE2Q48840457-B353FFD8-7B78-4481-AC0F-F37619B2F38AQ50063111-595BB774-70E2-4D01-9484-F8593F07541FQ52680964-6F5A10F0-4CFF-4E46-A472-C0C9C05CA7B4Q53172768-B512EB98-8115-4A48-966D-71B0ADF101DBQ58782280-1765C6C2-F79B-401C-BA4B-FA2C0616C206
P2860
Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improved outcome of patients o ...... entional conditioning regimen.
@en
Improved outcome of patients o ...... entional conditioning regimen.
@nl
type
label
Improved outcome of patients o ...... entional conditioning regimen.
@en
Improved outcome of patients o ...... entional conditioning regimen.
@nl
prefLabel
Improved outcome of patients o ...... entional conditioning regimen.
@en
Improved outcome of patients o ...... entional conditioning regimen.
@nl
P2093
P2860
P1433
P1476
Improved outcome of patients o ...... entional conditioning regimen.
@en
P2093
Andrea Bacigalupo
Jakob R Passweg
Judith Marsh
Mahmoud Aljurf
Paolo Anderlini
Rosi Oneto
Severe Aplastic Anemia Working ...... w Transplantation (EBMT-SAAWP)
Sébastien Maury
P2860
P304
P356
10.3324/HAEMATOL.2009.006916
P50
P577
2009-09-01T00:00:00Z